Plain-English translation of NCT07018713 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing ® injections as a way to prevent chronic migraines. The medication is injected into specific muscles in the head and neck to see if it reduces the number of migraine days people experience. Researchers want to compare how well this treatment works compared to placebo injections (injections with no active medication).
Chronic migraine is a serious condition that causes significant suffering and disrupts daily life for many people. This trial is exploring whether this medication could offer a new way to prevent migraines before they start, rather than just treating them after they occur.
You likely qualify if…
You likely don't qualify if…
Over about one year, you would visit the clinic four times to receive injections into muscles in your head and neck area (roughly 12 weeks apart). You would also have about 14 total visits—most done by phone or video call from home, with a few in-person visits. During this time, you would keep a headache diary to track how many migraine days you have, so researchers can compare whether the medication reduces your migraine frequency compared to placebo.
AI-generated summary from trial data · Jun 1, 2026 · Not medical advice
United States